SCHEMBL20834124

SCHEMBL20834124

COc1ccccc1-c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)nn1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PORCN Q9H237 1/20 0.74
▸ ALOX15 P16050 1/20 0.70
▸ TP53 P04637 3/20 0.61
▸ LMNA P02545 3/20 0.59
▸ CYP1A2 P05177 1/20 0.58
▸ RXFP1 Q9HBX9 6/20 0.56
▸ USP2 O75604 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ TSHR P16473 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ CYP2C9 P11712 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819184 0.90 PORCN (0.65) PORCNALOX15TP53LMNACYP1A2
SCHEMBL20819142 0.89 PORCN (0.79) PORCNALOX15TP53LMNACYP1A2
SCHEMBL30145219 0.89 PORCN (0.79) PORCNALOX15TP53LMNACYP1A2
Etc-159 SCHEMBL29381546 0.85 PORCN (1.00) PORCNALOX15TP53CYP1A2RXFP1
Etc-159 SCHEMBL17626176 0.85 PORCN (1.00) PORCNALOX15TP53CYP1A2RXFP1
SCHEMBL10114488 0.83 ALOX15 (1.00) ALOX15TP53LMNACYP1A2RXFP1
SCHEMBL17626253 0.83 ALOX15 (0.74) PORCNALOX15TP53LMNACYP1A2
SCHEMBL18166728 0.83 LMNA (0.79) ALOX15TP53LMNACYP1A2RXFP1
SCHEMBL22375237 0.82 PORCN (0.71) PORCNALOX15TP53CYP1A2RXFP1
SCHEMBL17628692 0.82 PORCN (0.82) PORCNALOX15TP53CYP1A2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11186581-B2 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide as a Wnt pathway modulator AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2021-11-30 — — US disclosed
US-20200270255-A1 WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-08-27 — — US disclosed
WO-2019054941-A1 WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200270255-A1 WNT PATHWAY MODULATORS WNT1, WNT3A, WNT3 PORCN 3838/4885ALOX15 910/4885TP53 422/4885
US-11186581-B2 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide as a Wnt pathway modulator WNT1, WNT3A, WNT3 PORCN 3817/4885ALOX15 918/4885TP53 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback